Scenario 2:Cardiac Medications Patient on digoxin starts taking potassium supplements. Analysis: 1. Type of interaction? __ 2. Safety concerns? __ 3 . Monitoring required? __ 4 Documentation needed? __

## Step 1<br />The interaction between digoxin and potassium supplements is a pharmacokinetic interaction. This is because the absorption, distribution, metabolism, and excretion of digoxin can be affected by the potassium supplements.<br /><br />## Step 2<br />The safety concern in this scenario is the potential for digoxin toxicity. This is because potassium supplements can increase the concentration of digoxin in the blood, leading to toxicity. Symptoms of digoxin toxicity include nausea, vomiting, loss of appetite, and vision changes.<br /><br />## Step 3<br />Monitoring is required in this scenario to ensure that the patient does not develop digoxin toxicity. This can be done by regularly checking the patient's potassium levels and monitoring for symptoms of toxicity.<br /><br />## Step 4<br />Documentation is needed in this scenario to ensure that the healthcare providers are aware of the potential interaction and can monitor the patient accordingly. This documentation should include the patient's medication regimen, any changes to the regimen, and any symptoms the patient may be experiencing.